Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis

Proteomics

Volumn 12, Issue 7, 2012, Pages 979-991

  Cho, Yun Sang ^a,e   Dobos, Karen M ^a   Prenni, Jessica ^a   Yang, Hongliang ^a   Hess, Ann ^a   Rosenkrands, Ida ^b   Andersen, Peter ^b   Ryoo, Sung Weon ^c   Bai, Gill Han ^c   Brennan, Michael J ^d,f   Izzo, Angelo ^a   Bielefeldt Ohmann, Helle ^a,g   Belisle, John T ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b STATENS SERUM INSTITUT   (Denmark)

^c Korea Institute of Tuberculosis   (South Korea)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^f AERAS Global Tuberculosis Foundation   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

DTH Microbiology; Mycobacterium tuberculosis; PPD

Indexed keywords

CHAPERONE; CHAPERONIN; HEAT SHOCK PROTEIN; PROTEIN DNAK; PROTEIN GROEL2; PROTEIN HSPX; PROTEOME; REAGENT; T LYMPHOCYTE ANTIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIAGNOSTIC PROCEDURE; FOOD AND DRUG ADMINISTRATION; GENE PRODUCT; GUINEA PIG; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VIVO STUDY; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; SOLUBILITY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GUINEA PIGS; MYCOBACTERIUM TUBERCULOSIS; PROTEOME; TUBERCULIN; TUBERCULOSIS;

EID: 84859952856     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100544     Document Type: Article

References (74)

1. Koch, R., Weitere Mittheilungen uber das Tuberkulin. Dt. Med. Wochenschr. 1891, 17, 1189-1192.
2. von Pirquet, C., Freguency of tuberculosis in childhood. J. Am. Med. Assoc. 1909, 52, 675-678.
3. Seibert, F. B., The isolation of a crystalline protein with tuberculin activity. Science 1926, 63, 619-620.
4. Seibert, F. B., Glenn, J. T., Tuberculin purified protein derivative. Preparation and analysis of a large quantity for standard. Am. Rev. Tubercul. 1941, 44, 9-25.
5. Comstock, G. W., Edwards, L. B., Philip, R. N., Winn, W. A., A comparison in the United States of America of two tuberculins, PPD-S and RT23. Bull. World Health Organ. 1964, 31, 161-170.
6. Guld, J., Bentzon, M. W., Bleiker, M. A., Griep, W. A. et al., Standardization of a new batch of purified tuberculin (PPD) intended for international use. Bull. World Health Organ. 1958, 19, 845-951.
7. Villarino, M. E., Brennan, M. J., Nolan, C. M., Catanzaro, A. et al., Comparison testing of current (PPD-SI) and proposed (PPD-S2) reference tuberculin standards. Am. J. Respir. Crit. Care Med. 2000, 161, 1167-1171.
8. Coler, R. N., Skeiky, Y. A., Ovendale, P. J., Vedvick, T. S. et al., Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J. Infect. Dis. 2000, 182, 224-233.
9. Kitaura, H., Kinomoto, M., Yamada, T., Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity. Scand. J. Immunol. 1999, 50, 580-587.
10. Kuwabara, S., Purification and properties of tuberculin-active protein from Mycobacterium tuberculosis. J. Biol. Chem. 1975, 250, 2556-2562.
11. Kuwabara, S., Amino-acid sequence of tuberculin-active protein from Mycobacterium tuberculosis. J. Biol. Chem. 1975, 250, 2563-2568.
12. Malen, H., Berven, F. S., Fladmark, K. E., Wiker, H. G., Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007, 7, 1702-1718.
13. Mawuenyega, K. G., Forst, C. V., Dobos, K. M., Belisle, J. T. et al., Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 2005, 16, 396-404.
14. Rosenkrands, I., Weldingh, K., Jacobsen, S., Hansen, C. V. et al., Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis 2000, 21, 935-948.
15. Urquhart, B. L., Cordwell, S. J., Humphery-Smith, I., Comparison of predicted and observed properties of proteins encoded in the genome of Mycobacterium tuberculosis H37Rv. Biochem. Biophys. Res. Commun. 1998, 253, 70-79.
16. Betts, J. C., Dodson, P., Quan, S., Lewis, A. P. et al., Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology 2000, 146(Pt 12), 3205-3216.
17. He, X. Y., Zhuang, Y. H., Zhang, X. G., Li, G. L., Comparative proteome analysis of culture supernatant proteins of Mycobacterium tuberculosis H37Rv and H37Ra. Microbes Infect. 2003, 5, 851-856.
18. Jiang, X., Zhang, Y., Zhang, W., Gao, F. et al., Identification of unique genetic markers in Rv0927c among Mycobacterium tuberculosis W-Beijing strains. Microbes Infect. 2007, 9, 241-246.
19. Jungblut, P. R., Schaible, U. E., Mollenkopf, H. J., Zimny-Arndt, U. et al., Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol. 1999, 33, 1103-1117.
20. Mattow, J., Jungblut, P. R., Schaible, U. E., Mollenkopf, H. J. et al., Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis 2001, 22, 2936-2946.
21. Pheiffer, C., Betts, J. C., Flynn, H. R., Lukey, P. T. et al., Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 2005, 151, 1139-1150.
22. Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A. et al., Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 2002, 43, 717-731.
23. Boon, C., Li, R., Qi, R., Dick, T., Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J. Bacteriol. 2001, 183, 2672-2676.
24. Cho, S. H., Goodlett, D., Franzblau, S., ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2006, 86, 445-460.
25. Florczyk, M. A., McCue, L. A., Stack, R. F., Hauer, C. R. et al., Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect. Immun. 2001, 69, 5777-5785.
26. Rosenkrands, I., Slayden, R. A., Crawford, J., Aagaard, C. et al., Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J. Bacteriol. 2002, 184, 3485-3491.
27. Starck, J., Kallenius, G., Marklund, B. I., Andersson, D. I. et al., Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 2004, 150, 3821-3829.
28. Wong, D. K., Lee, B. Y., Horwitz, M. A., Gibson, B. W., Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect. Immun. 1999, 67, 327-336.
29. Yuan, Y., Crane, D. D., Barry, C. E., 3rd, Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J. Bacteriol. 1996, 178, 4484-4492.
30. Covert, B. A., Spencer, J. S., Orme, I. M., Belisle, J. T., The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics 2001, 1, 574-586.
31. Malen, H., Berven, F. S., Softeland, T., Arntzen, M. O. et al., Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics 2008, 8, 1859-1870.
32. Sable, S. B., Kumar, R., Kalra, M., Verma, I. et al., Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infect. Immun. 2005, 73, 3547-3558.
33. Samanich, K. M., Belisle, J. T., Sonnenberg, M. G., Keen, M. A. et al., Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J. Infect. Dis. 1998, 178, 1534-1538.
34. Sartain, M. J., Slayden, R. A., Singh, K. K., Laal, S. et al., Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol. Cell. Proteomics 2006, 5, 2102-2113.
35. Wiker, H. G., Unmatched sequences in public databases-exemplified by tuberculin-active protein. Scand. J. Immunol. 2004, 59, 607-608.
36. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T. et al., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393, 537-544.
37. Washburn, M. P., Wolters, D., Yates, J. R., 3rd, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
38. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F. et al., Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246, 64-71.
39. Hirosawa, M., Hoshida, M., Ishikawa, M., Toya, T., MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput. Appl. Biosci. 1993, 9, 161-167.
40. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E. et al., Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
41. Paoletti, A. C., Parmely, T. J., Tomomori-Sato, C., Sato, S. et al., Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl. Acad. Sci. USA 2006, 103, 18928-18933.
42. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
43. Aitken, A., Learnmonth, M., in: Walker, J. M. (Ed.), The Protein Protocols Handbook, Humana Press, Totowa, NJ 2002, pp. 455-456.
44. Lee, B. Y., Hefta, S. A., Brennan, P. J., Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect. Immun. 1992, 60, 2066-2074.
45. Hellman, U., Wernstedt, C., Gonez, J., Heldin, C. H., Improvement of an in-gel digestion procedure for the micropreparation of internal protein-fragments for amino-acid sequencing. Anal. Biochem. 1995, 224, 451-455.
46. Vizcaino, J. A., Cote, R., Reisinger, F., Barsnes, H. et al., The Proteomics Identifications database: 2010 update. Nucleic Acids Res. 2010, 38, D736-D742.
47. Paoletti, A. C., Parmely, T. J., Tomomori-Sato, C., Sato, S. et al., Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl. Acad. Sci. USA 2006, 103, 18928-18933.
48. Searle, B. C., Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies. Proteomics 2010, 10, 1265-1269.
49. Mehaffy, C., Hess, A., Prenni, J. E., Mathema, B. et al., Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics 2010, 10, 1966-1984.
50. Affronti, L. F., in: Bendinelli, M., Friedman, H. (Eds.), Mycobacterium Tuberculosis Interactions with the Immune Sysytem, Plenum Press, New York 1988, pp. 1-37.
51. Aebersold, R., Goodlett, D. R., Mass spectrometry in proteomics. Chem. Rev. 2001, 101, 269-295.
52. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
53. Belisle, J. T., Braunstein, M., Rosenkrands, I., Andersen, P. (Eds.), The Proteome of Mycobacterium Tuberculosis, American Society for Microbiology, Washington, DC 2005.
54. Dobos, K. M., Belisle, J. T. (Eds.), Proteomics of Mycobacterium Tuberculosis, Wiley-VCH, Darmstadt 2008.
55. Vita, R., Zarebski, L., Greenbaum, J. A., Emami, H., Hoof, I. et al., The immune epitope database 2.0. Nucleic Acids Res. 2010, 38, D854--D862.
56. Sable, S. B., Plikaytis, B. B., Shinnick, T. M., Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens. Vaccine 2007, 25, 1553-1566.
57. Cho, S., Mehra, V., Thoma-Uszynski, S., Stenger, S. et al., Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 2000, 97, 12210-12215.
58. Lee, E., Holzman, R. S., Evolution and current use of the tuberculin test. Clin. Infect. Dis. 2002, 34, 365-370.
59. Basaraba, R. J., Izzo, A. A., Brandt, L., Orme, I. M., Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine 2006, 24, 280-286.
60. Reece, S. T., Stride, N., Ovendale, P., Reed, S. G. et al., Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs. Infect. Immun. 2005, 73, 3301-3306.
61. Brodin, P., Rosenkrands, I., Andersen, P., Cole, S. T. et al., ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 2004, 12, 500-508.
62. Haslov, K., Tuberculin PPD RT23 is stable: quality control data cannot be denied. Int. J. Tuberc. Lung Dis. 1998, 2, 946.
63. Haslov, K., Ponce-de-Leon Rosales, S., Rangel-Frausto, S., Olesen Larsen, S., Tuberculin PPD RT23: still going strong. Int. J. Tuberc. Lung Dis. 1998, 2, 793-795.
64. Harboe, M., Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am. Rev. Respir. Dis. 1981, 124, 80-87.
65. Borsuk, S., Newcombe, J., Mendum, T. A., Dellagostin, O. A. et al., Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS. Tuberculosis (Edinb.) 2009, 89, 423-430.
66. Ishihama, Y., Oda, Y., Tabata, T., Sato, T. et al., Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics 2005, 4, 1265-1272.
67. Perkins, M. D., New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis. 2000, 4, S182-S188.
68. Hussain, R., Shahid, F., Zafar, S., Dojki, M. et al., Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents. Immunology 2004, 111, 462-471.
69. Farhat, M., Greenaway, C., Pai, M., Menzies, D., False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 2006, 10, 1192-1204.
70. Floto, R. A., MacAry, P. A., Boname, J. M., Mien, T. S. et al., Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 2006, 314, 454-458.
71. Javid, B., MacAry, P. A., Lehner, P. J., Structure and function: heat shock proteins and adaptive immunity. J. Immunol. 2007, 179, 2035-2040.
72. Tobian, A. A., Canaday, D. H., Harding, C. V., Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells. J. Immunol. 2004, 173, 5130-5137.
73. Qamra, R., Mande, S. C., Coates, A. R. M., Henderson, B., The unusual chaperonins of Mycobacterium tuberculosis. Tuberculosis 2005, 85, 385-394.
74. Yang, H., Troudt, J., Grover, A., Arnett, K. et al., Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection. Infect. Immun. 2011, 79, 716-723.